BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:Pacific Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:Pacific Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260603T150000
DTEND;TZID=America/Los_Angeles:20260603T173000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Commuter Conference: Manufacturing and Quality Control of Microbiome Derived Live Biotherapeutic Products for Improving Human Health
DESCRIPTION:Living inside every person are trillions of bacteria and other life forms that make up the microbiome. Novel therapeutics using living bacteria known as Live Biotherapeutic Products (LBPs) derived from the microbiome are being developed to prevent\, treat\, or cure diseases such as gut\, neurodegenerative\, and psychiatric disorders\, infections\, infertility\, and cancer. This burgeoning field presents unique manufacturing challenges and quality control considerations. Unlike traditional pharmaceuticals\, LBPs are alive. Maintaining viability through the entire manufacturing process is critical. In addition\, live bacteria in the product make standard microbial tests (compendial methods such as USP 61 / 62 ) inherently problematic\; high concentrations of the product strain can overwhelm testing media\, mask contamination\, or render filtration methods unusable. Learn how List Labs is tackling these challenges including developing tailored processes and organism-specific quality control methods to harness bacteria's potential for a healthier world.PRESENTERSNuria Gonzales\, Director of Biologics Development\nSarah Henning\, Sr Manager of Quality Control\nSarah Henning is the Senior Manager of Quality Control at List Biological Labs\, where she specializes in QC method development for bacterial products and recombinant proteins. With nearly a decade of experience in public health and pharmaceutical microbiology\, she is passionate about advancing the field in Live Biotherapeutics. A key opinion leader in the industry\, Sarah recently presented at a national conference for microbiome research\, sharing her insights on creating novel processes for contaminant detection and ensuring product safety. When not at the office\, you can find her exploring the California coast with her two dogs\, playing volleyball\, and volunteering for a local animal sanctuary. Connect with Sarah on LinkedIn.com/in/sarahchenning
X-ALT-DESC;FMTTYPE=text/html:Living inside every person are trillions of bacteria and other life forms that make up the microbiome. Novel therapeutics using living bacteria&mdash\;known as Live Biotherapeutic Products (LBPs) derived from the microbiome&mdash\;are being developed to prevent\, treat\, or cure diseases such as gut\, neurodegenerative\, and psychiatric disorders\, infections\, infertility\, and cancer. This burgeoning field presents unique manufacturing challenges and quality control considerations. Unlike traditional pharmaceuticals\, LBPs are alive. Maintaining viability through the entire manufacturing process is critical. In addition\, live bacteria in the product make standard microbial tests (compendial methods such as USP <\;61>\;/<\;62>\;) inherently problematic\; high concentrations of the product strain can overwhelm testing media\, mask contamination\, or render filtration methods unusable. Learn how List Labs is tackling these challenges&mdash\;including developing tailored processes and organism-specific quality control methods&mdash\;to harness bacteria&rsquo\;s potential for a healthier world.
PRESENTERS
Nuria Gonzales\, Director of Biologics Development
Sarah Henning\, Sr Manager of Quality Control
Sarah Henning is the Senior Manager of Quality Control at List Biological Labs\, where she specializes in QC method development for bacterial products and recombinant proteins. With nearly a decade of experience in public health and pharmaceutical microbiology\, she is passionate about advancing the field in Live Biotherapeutics. A key opinion leader in the industry\, Sarah recently presented at a national conference for microbiome research\, sharing her insights on creating novel processes for contaminant detection and ensuring product safety. When not at the office\, you can find her exploring the California coast with her two dogs\, playing volleyball\, and volunteering for a local animal sanctuary. Connect with Sarah on LinkedIn.com/in/sarahchenning
LOCATION:540 Divison Street Campbell CA 95008
UID:e.4613.1422108
SEQUENCE:3
DTSTAMP:20260501T015329Z
URL:https://members.ispesf.org/bod-calendar/Details/commuter-conference-manufacturing-and-quality-control-of-microbiome-derived-live-biotherapeutic-products-for-improving-human-health-1681496?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR